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ABSTRACT
Objective: To evaluate associations between vascular risk factors and changes in burden of
infarcts, ventricular size (VS), sulcal widening (SW), and white matter hyperintensities (WMH)
in an initially middle-aged, biracial cohort from the Atherosclerosis Risk in Communities (ARIC)
study.
Methods: Initial brain magnetic resonance (MR) scans and evaluations for vascular risk factors
were performed in 1,812 ARIC participants in 1994–1995. In 2004–2006, 1,130 ARIC partic-
ipants underwent repeat MR scans. MR scans were rated using a validated 9-point scale for VS,
SW, and WMH. Infarcts were recorded. Multiple logistic regression analysis was used to assess
associations between vascular risk factors and change between MR scans of one or more grades
in VS, SW, WMH, or appearance of new infarcts, controlling for age, sex, and race.
Results: At baseline, the 1,112 participants with usable scans (385 black women, 200 black men,
304 white women, 223 white men) had a mean age of 61.7  4.3 years. In adjusted models,
diabetes at baseline was associated with incident infarcts (odds ratio [OR] 1.95, 95% confidence
interval [CI] 1.29–2.95) and worsening SW (OR 2.10, 95% CI 1.36–3.24). Hypertension at base-
line was associated with incident infarcts (OR 1.73, 95% CI 1.23–2.42). In subjects with the
highest tertile of fasting blood sugar and systolic blood pressure at baseline, the risk of incident
infarcts was 3.68 times higher (95% CI 1.89–7.19) than those in the lowest tertile for both.
Conclusion: Both atrophic and ischemic imaging changes were driven by altered glycemic and
blood pressure control beginning in midlife. Neurology® 2011;76:1879–1885
GLOSSARY
ARIC  Atherosclerosis Risk in Communities; CI  confidence interval; MR  magnetic resonance; OR  odds ratio; SW 
sulcal widening; VS  ventricular size; WMH  white matter hyperintensity.
Midlife vascular risk factors are well-known to be associated with late-life cognitive impairment
and dementia,1,2 but the mechanisms by which midlife vascular risk factors cause brain injury
are not well-understood. Both ischemic and degenerative pathways are likely involved, but
speculation abounds about their relative contributions. There are few autopsy studies in per-
sons in midlife, so what disease-related processes are occurring in midlife must be inferred from
late-life neuropathologic studies,3,4 or from brain imaging. Brain imaging in middle-aged pop-
ulations has begun to address the issue, but most work is cross-sectional. Cross-sectional studies
have shown associations with vascular risk factors and imaging features.5-8 There are only a few
longitudinal studies9-12 of white matter hyperintensities (WMH) and infarcts, but only one
study13 that we are aware of has assessed the impact of vascular risk factors on brain atrophy.
e-Pub ahead of print on May 4, 2011, at www.neurology.org.
From the Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Medicine (A.D.P., T.H.M.), University of Mississippi
Medical Center, Jackson; Department of Biostatistics (D.J.C.), University of North Carolina, Chapel Hill; Division of Public Health Sciences
(L.H.C.), Wake Forest University School of Medicine, Winston-Salem, NC; Department of Radiology (D.K.S.), University of Washington Medical
Center, Seattle; and Bloomberg School of Public Health (A.R.S.), Department of Epidemiology, Johns Hopkins University, Baltimore, MD.
Study funding: The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood
Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C,
HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). This work was also supported by grant R01- HL70825.






reprint requests to Dr. David
Knopman, Department of
Neurology, Mayo Clinic College
of Medicine, 200 First Street SW,
Rochester, MN 55905
knopman@mayo.edu
Copyright © 2011 by AAN Enterprises, Inc. 1879
We carried out MRI in an initially
middle-aged cohort from the Atherosclero-
sis Risk in Communities (ARIC) study and
have reported on the cross-sectional associ-
ations of cognitive and risk factor correlates
with magnetic resonance (MR) findings.5,14
Diabetes and hypertension were the 2 most
important vascular risk factors in those
analyses. MR scans were repeated in over
half of the original participants roughly 10
years later. The goal of the present analysis
is to describe the imaging changes and their
relationships to the presence of diabetes and
hypertension, as well as other risk factors.
We sought to learn whether vascular risk
factors were associated with ischemic and
atrophic brain imaging changes.
METHODS Design and patients. At inception in 1987–
1989, the ARIC study recruited 15,792 women and men,
aged 45– 64, from probability samples in 4 US communities:
Forsyth County, NC; Jackson, MS (black subjects only); se-
lected suburbs of Minneapolis, MN; and Washington
County, MD. Details of the ARIC study sampling and study
design have been published.15 The current analyses involve a
subset of the original ARIC cohort who participated in the
ARIC MRI Study (2004 –2006). These individuals were re-
cruited for a follow-up brain MR scan and cognitive testing
from the subset of the ARIC cohort (n  1,812) who had an
initial MR scan at the third ARIC examination.
During the first 2 years (1993 and 1994) of the third ARIC
examination, 2,891 participants aged 55 and older from the
ARIC study sites in Forsyth County and Jackson were invited for
cerebral MRI and cognitive assessment. Cognitive assessments
and vascular risk factor assessments were conducted at this visit,
and the vascular risk factors recorded at this third ARIC visit
constitute the baseline for the present analyses. For reasons of
participant safety, the following exclusion criteria were used for
selection of participants in 1993–1994: prior surgery for an an-
eurysm in the brain; metal fragments in the eyes, brain, or spinal
cord; valvular prosthesis, cardiac pacemaker, cochlear implant,
spinal cord stimulator, or other internal electrical device; and
occupations associated with exposure to metal fragments. Of
those screened, 2% of women and 6% of men were ineligible. A
total of 1,945 participants successfully underwent cerebral MRI,
1,812 of whom had scans of sufficient quality to perform ratings.
The cognitive and vascular risk factor relationships to the imag-
ing obtained in 1993–1994 have been previously described.5,14
Between 2004 and 2006, 10 years after the initial MR scans,
all participants who had undergone MR scanning at the third
ARIC visit were invited to participate in the ARIC MRI study
and undergo a repeat MR and cognitive assessment. There were
1,112 (African American 585, white 527) subjects who had both
an initial scan and a follow-up scan of sufficient quality for anal-
ysis, as well as assessment of vascular risk factors at the time of
the initial MR scan 10 years earlier, who form the study group
for this report. There were 808 subjects who did not undergo
scanning because of death (n  268), refusal (n  452), requests
for no further contact with study (n  20), neurologic disorders
(n  13), surgery/radiation to skull/brain (n  9), or ineligible
(n  46). The flow of subjects is also shown in figure e-1 on the
Neurology® Web site at www.neurology.org.
Standard protocol approvals and patient consents. All
subjects provided written informed consent to participate, based
on local standards at Wake Forest University School of Medicine
or the University of Mississippi Medical Center.
Risk factors. Risk factor measurements were obtained in
1993–1994 at the time of the third ARIC visit, with the excep-
tion of strokes, which were captured on an ongoing basis. These
have been described previously,5,16 so only those measurements
for risk factors pertinent to the current report are included here.
Prevalent diabetes mellitus was defined as a fasting glucose of
126 mg/dL, nonfasting glucose of 200 mg/dL, a self-
reported history of diabetes, or treatment for diabetes in the past
2 weeks. Serum glucose was assessed by the hexokinase method.
Hypertension was defined as systolic blood pressure 140
mm Hg, diastolic blood pressure 90 mm Hg, or use of antihy-
pertensive medications in the past 2 weeks.
Prevalent stroke prior to first MR was defined as a stroke
validated by an ARIC physician through review of medical re-
cords17,18 occurring prior to the first MR scan.
Incident stroke was similarly defined as stroke occurring after
baseline validated by an ARIC clinician through review of medical
records occurring after baseline. The identification and validation of
incident strokes is complete to December 31, 2004. Approximately
90% of incident strokes were characterized as ischemic (embolic or
thrombotic strokes), the remainder as hemorrhagic.
APOE genotype determinations were available on most sub-
jects. Genotyping of the APOE polymorphisms was performed
using the TaqMan assay (Applied Biosystems, Foster City, CA).
The current analyses were done using a dichotomous variable to
represent the presence or absence of an 4 allele.
Imaging measures. At the time that the original scans were
obtained, quantitative volumetric brain imaging was not avail-
able, and consequently, our analyses used visual ratings of white
matter hyperintensities, ventricular volume, and sulcal width.
While visual ratings lack the precision of volumetric analyses,
there is an excellent correspondence between the 2 methods.19
See figure e-2 for templates for the imaging ratings.
All scans were performed at 1.5 T and included axial 5-mm
contiguous T1, T2, and proton density–weighted images. The base-
line brain MRs in 1993–1994 were obtained on GE or Picker scan-
ners, and were interpreted at the ARIC MRI Reading Center at
Johns Hopkins Medical Institutions using a scoring protocol devel-
oped and validated by the Cardiovascular Health Study.20,21 Results
using the baseline scans have been reported.5,14,22
The follow-up MR scans were performed in 2004–2006 (all
on GE scanners), as part of the ARIC MRI study. Although
there were interval hardware and software upgrades, these studies
were again obtained on 1.5 T scanners and the parameters used
for scanning were chosen to match as closely as possible the
signal-to-noise, resolution, and contrast weighting used for the
earlier scans. These scans were scored at the University of Wash-
ington by neuroradiologists who were trained by one of the read-
ers involved in the baseline study. The current study
neuroradiologists were tested on a sample of the earlier scans to
verify highly similar scoring. The criterion was 85% agreement
within one grade for the WMH, sulci, and ventricle grading and
85% agreement for the presence or absence of infarcts com-
pared to the original adjudicated scoring. This level of concor-
dance was chosen to be similar to the interreader agreement from
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the baseline scoring. Thus, it was assured that both the scan
technique and the scoring of the follow-up scans were as similar
as possible to the baseline scans.
The ratings for the baseline and follow-up scans were obtained
independently. We did not perform side-to-side comparisons.
Infarcts were defined based on signal characteristics on T1,
T2, and proton density images: bright on T2 and proton density
and dark on T1 images. Infarcts were counted only if they were
3 mm in maximum diameter. All scans were subjected to
double-reads for infarcts scoring, and scans with discrepancies in
numbers of infarcts between readers were read a third time for
adjudication. A reliability exercise using 104 randomly selected
cases was carried out, and interrater agreement was 89%.19
Proton density images were used to estimate the extent of
white matter hyperintensities (WMH). Periventricular and sub-
cortical WMH were combined for these analyses. The burden of
WMH was rated on a 0–9 scale as previously described for
ARIC22 and Cardiovascular Health Study.6 An analysis of the
visually rated WMH burden had an excellent linear correlation
with quantitatively estimated WMH (R2  0.75).19 Interrater
reliability for WMH showed a weighted  of 0.76.
Axial T1-weighted images were used for assessment of ventricu-
lar size (VS) and sulcal width (SW) using a 0 to 9 scale.20,21 An
analysis of the visual ratings compared to quantitative estimates of
ventricular volume showed an excellent correlation (R2  0.79) in a
subsample of scans from 2004 to 2006.19 The reliability coefficients
for 26 pairs of readings by 2 independent neuroradiologists for
VS  0.87, SW  0.63, and WMH  0.94.
Analytic procedures. All outcomes were dichotomized for
WMH, VS, and SW. The outcomes were worsening of one or
more grades vs no change; for incident infarcts, present vs ab-
sent. Multiple logistic regression (SAS Institute, Cary, NC) was
used to estimate outcome odds ratios (OR) and 95% confidence
intervals (CI) for each vascular risk factor individually, control-
ling for age, sex, and race. For continuous risk factors, the unit of
difference was 1 SD. Cases with missing data were excluded from
analyses. Based on our prior studies,5,16 prevalent stroke, incident
stroke, diabetes, and hypertension were the risk factors of pri-
mary interest. All other risk factors were considered exploratory.
With 4 imaging features and 3 risk factors, our analyses involve
multiple applications of statistical testing. We used a p value of
0.05, however, because the association of a risk factor with one
imaging feature is likely to be correlated with the other imaging
features.
Differences in associations among the imaging features
should be viewed with the caveat that the metrics for each are
different. For example, one incident infarct is not equivalent to
an increase in one grade of SW, VS, or WMH.
RESULTS Demographics and baseline vascular risk
factor status of the 1,112 subjects with usable scans
are shown in table 1. There were notable differences
between racial and gender groups in the prevalence
of diabetes, hypertension, and stroke. Compared to
current participants, those who died, were ineligible,
or refused to participate in the follow-up scan were
older, had a much higher stroke rate, had a higher
rate of diabetes and hypertension, and had worse im-
aging at the baseline scan (table e-1).16
Over a median interval of 10.6 years between
scans, most subjects experienced worsening of VS,
SW, and WMH, but only 20% experienced new in-
farcts (table 2). Older age was strongly associated
with worsening of imaging features (table e-2). For
example, the number of subjects with new infarcts
was 16.1% in the 55–59 year age group, but 25.4%
in the 65- to 72-year-old subjects. Infarct incidence
was weakly correlated with changes in WMH (Pear-
son correlation 0.17) but virtually uncorrelated with
changes in VS or SW (Pearson correlation coeffi-
cients of 0.06 and 0.04, respectively). Black subjects
had more infarcts at baseline and more increase in
WMH (table 2) but ethnic differences were generally
small for the other MR features.
Measures of glycemic control and blood pressure
were associated with progression of all 4 imaging fea-
tures (table 3). Other risk factors showed associations
with one or more imaging feature (table e-3), but
glycemic control and hypertension alone were the
only risk factors that were associated with both isch-
emic changes and atrophic changes. APOE 4 geno-
type was not associated with any changes in imaging
features. There was, as expected, a strong association
between incident infarcts and incident stroke.
In all 3 multivariable models (table 4), both dia-
betes and hypertension at baseline were strongly and
Table 1 Characteristics of the ARIC MRI study population at baseline
MR examination
Black White
AllFemale Male Female Male
No. of subjects 385 200 304 223 1,112
Age, y, mean  SD 61.1  4.3 61.0  4.5 62.4  4.3 62.3  4.1 61.7  4.3
Years of education, %
<8 14.8 17.5 1.0 3.6 9.3
9–12 38.7 27.0 49.7 30.5 37.9
>12 46.2 55.5 49.3 65.9 52.7
Any APOE 4 allele, % 33.2 33.5 22.4 24.2 28.5
Body mass index, kg/m2,
mean  SD
30.3  5.1 27.9  4.1 25.7  4.4 26.7  3.3 28.0  4.8
Diabetes at the time of
first MR scan, %
21.6 21.5 5.9 11.2 15.2
Hypertension at the time
of first MR scan, %
63.9 48.0 26.6 31.8 44.4
Stroke prior to first
MR scan, %




3.6 4.0 0.7 1.8 2.5
Current smoker, % 13.0 18.5 17.1 9.9 14.5
Former smoker, % 26.8 45.0 27.0 65.9 37.9
Current drinker, % 22.6 40.0 46.4 59.2 39.6
Former drinker, % 23.6 35.0 9.9 24.2 22.0
Abbreviations: ARIC  Atherosclerosis Risk in Communities; MR  magnetic resonance.
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independently associated with incident infarcts. Dia-
betes alone was associated with worsening SW in all
3 models.
At baseline, 539 (50.3%) subjects were free of
both hypertension and diabetes (“low vascular risk”)
and 99 (9.2%) had both (“high vascular risk”). Inci-
dent infarcts were seen in 32.6% of the high vascular
risk group compared to 15.1% in the low vascular
risk group. The corresponding figures for change of
one grade or more in the other MRI features were
84.7% vs 73.2% for VS progression, 76.5% vs
55.5% for WMH progression, and 80.0% vs 69.6%
for SW progression. The combined effect of hyper-
tension and diabetes was further illustrated by an
analysis by tertiles of fasting blood sugar, systolic
blood pressure, and risk for incident infarcts. Those
in the highest tertile for both fasting blood sugar and
systolic blood pressure had 3.68 higher risk (95% CI
1.89–7.19) of new infarcts compared to subjects in
the lowest tertile for both conditions (figure 1). Anal-
yses with VS, SW, and WMH progression showed
no consistent pattern for the combined factors and
ORs were low (data not shown).
We examined the risk factors in table 4 separately
for men, women, and black and white subjects and
found differences in the pattern of associations
achieving p values of 0.05 between gender and ra-
cial groups. However, in models that included all
subjects, none of the interaction terms for race or
gender were significant.
DISCUSSION There are several important findings
from this study of serial imaging of an initially middle-
aged cohort. First, over two-thirds of the ARIC MRI
study participants experienced a detectable worsening
of VS, SW, and WMH over the 10-year interval. Ap-
proximately 20% experienced new infarcts, the vast ma-
jority of which were lacunar. Second, altered glycemic
control and hypertension were associated with incident
infarcts and to a less consistent degree, worsening of VS,
SW, or WMH. Third, altered glycemic control and el-
evated blood pressure were independent of one another,
and for infarcts, showed additive effects. Fourth, despite
the substantial differences at baseline across racial and
gender groups, there were no race- or sex-specific inter-
actions between changes in brain imaging and vascular
risk factors, APOE 4 genotype, or stroke history. Our
observations from this longitudinal study offer convinc-
ing evidence for a causal relationship between altera-
tions in glycemic control and blood pressure and
subsequent brain ischemic and atrophic changes.
Table 2 Proportion of ARIC MRI study population with imaging abnormalities
at baseline and progression of brain atrophy, white matter








male, % All, %
Status at baseline scan
Ventricular grade 4–9 8.3 14.0 10.5 17.0 11.7
Sulcal grade 3–6 21.6 31.5 21.1 24.7 23.8
White matter grade 3–8 7.0 10.5 9.9 5.8 8.2
Prevalent infarcts 10.4 7.0 6.6 5.4 7.7
Changes in imaging features at
follow-up
Ventricular size worsening of one
grade or more
73.5 80.0 78.5 74.5 76.3
Sulcal widening worsening of one
grade or more
64.0 63.3 77.2 78.8 70.7
White matter hyperintensity
worsening of one grade or more
70.0 70.0 56.4 50.9 62.1
Incident infarcts 20.9 20.3 20.7 17.9 20.1
Abbreviation: ARIC  Atherosclerosis Risk in Communities.
Table 3 Odds ratiosa (95% CI) for progression of MRI changes as a function of baseline levels of glycemic control, blood pressure control,
stroke, and APOE 4 genotype in all subjectsb
Risk factor
Ventricular grade Sulcal grade White matter grade Incident infarcts
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Diabetes present vs absent 1.42 (0.90–2.23) 2.10c (1.36–3.24) 1.44 (0.97–2.15) 1.95c (1.29–2.95)
Fasting glucose (per 1-SD increment) 1.07 (0.92–1.26) 1.20c (1.02–1.41) 1.25c (1.06–1.48) 1.27c (1.10–1.46)
Hypertension present vs absent 1.36 (0.99–1.87) 1.17 (0.87–1.57) 1.29 (0.97–1.70) 1.73c (1.23–2.42)
Systolic BP (per 1-SD increment) 1.28c (1.03–1.58) 1.21c (1.00–1.47) 1.01 (0.84–1.21) 1.54c (1.25–1.90)
Diastolic BP (per 1-SD increment) 0.76 (0.62–0.94) 0.90 (0.75–1.09) 1.15 (0.96–1.37) 0.94 (0.76–1.17)
Mean arterial BP (per 1-SD increment) 0.97 (0.83–1.13) 1.08 (0.94–1.25) 1.14 (0.99–1.31) 1.41c (1.20–1.66)
Incident stroke present vs absent 1.50 (0.51–4.46) 1.91 (0.70–5.19) 2.55 (0.85–7.60) 19.40c (6.41,58.70)
Prevalent stroke present vs absent 1.63 (0.55–4.89) 1.58 (0.57–4.33) 1.24 (0.53–2.90) 1.02 (0.33–3.11)
APOE 4 allele present vs absent 1.38 (0.98–1.96) 1.00 (0.73–1.38) 1.10 (0.81–1.49) 1.04 (0.72–1.50)
Abbreviations: BP  blood pressure; CI  confidence interval; OR  odds ratio.
a Adjusted for age (continuous), sex, and race.
b One or more grades of change in imaging features vs none: Atherosclerosis Risk in Communities MRI study.
c p  0.05.
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Strengths of the ARIC MRI study include the
large sample size, its biracial composition, extensive
risk factor assessment at baseline, and the 10-year
interval between scans. There are several weaknesses,
however. Loss of subjects over the 10 years of
follow-up to death and worsening disability is an un-
avoidable bias in any prospective study. Considering
that those persons who had follow-up scans were
healthier in all respects including lower burdens of
vascular risk factors, and less pathology on imaging,16
our findings probably understate the links between
diabetes and hypertension. Unfortunately, when the
first scans were obtained, volumetric MRI was not
available. We were unable to use volumetric tech-
niques for the serial comparisons. Our rating system
for imaging features has been validated, but it is
clearly less precise than newer quantitative tech-
niques. Despite our large sample size, there were few
APOE 4 homozygotes (n  33), precluding analysis
of homozygotes vs heterozygotes.
The associations of altered glycemic control and
hypertension with incident infarcts were the most
consistent across the different markers of each (table
3) that we evaluated. Even if the risk factors could
have other mechanisms, an ischemic one is not triv-
ial. Our findings are consistent with neuropathologic
studies of diabetic23-25 and hypertensive3,26 subjects
that have shown that these 2 risk factors are both
associated with infarcts.
Our observations on WMH also support a role
for vascular processes in the longitudinal evolution of
imaging changes with altered glycemic control and
hypertension. WMH are strongly associated with
cerebrovascular disease by imaging12 and pathol-
ogy.27 Both cross-sectional5,6,8,22 and longitudinal im-
aging including ones previously reported from this
same ARIC cohort28 and other studies10-12 have
shown associations between WMH and vascular risk
factors, most notably hypertension. Yet, in both
cross-sectional and longitudinal studies, the associa-
tions have been modest.
The lack of significant association of incident or
prevalent stroke with brain atrophy measures in the
present study suggests that atrophic processes and
Figure 1 Odds ratios of new infarcts by combinations of fasting blood
glucose levels and systolic blood pressure in all subjects
Tertiles of baseline systolic blood pressure are depicted on the x-axis, tertiles of baseline
fasting glucose are depicted on the y-axis, and odds ratios on the z-axis. The reference
group is the lowest tertile for both systolic blood pressure and fasting blood glucose. Gray
bars indicate odds ratios that did not include 1. The odds ratio of the group with the highest
tertile of systolic blood pressure and highest fasting blood glucose level was 3.68 (95%
confidence interval 1.89–7.19).
Table 4 Odds ratiosa (95% CI) for progression of cerebral ischemic burden as a function of cumulative diabetes or
cumulative hypertension
Risk factor
Ventricular grade Sulcal grade White matter grade Incident infarcts
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Diabetes (present
vs absent)
Model 1 1.42 (0.90–2.23) 2.10c (1.36–3.24) 1.44 (0.97–2.15) 1.95c (1.29–2.95)
Model 2 1.37 (0.87–2.16) 2.07c (1.34–3.21) 1.43 (0.96–2.14) 1.82c (1.20–2.76)
Model 3 1.31 (0.81–2.11) 2.10c (1.31–3.36) 1.24 (0.81–1.90) 1.96c (1.23–3.10)
Hypertension (present
vs absent)
Model 1 1.36 (0.99–1.87) 1.17 (0.87–1.57) 1.29 (0.97–1.70) 1.73c (1.23–2.42)
Model 2 1.30 (0.94–1.79) 1.11 (0.82–1.50) 1.25 (0.94–1.66) 1.60c (1.13–2.25)
Model 3 1.25 (0.89–1.76) 1.01 (0.74–1.39) 1.22 (0.90–1.64) 1.58c (1.08–2.30)
Abbreviations: CI  confidence interval; OR  odds ratio.
a Model 1: adjusted for age (continuous), sex, and race. Model 2: adjusted for age (continuous), sex, race, and diabetes mellitus or hypertension. Model 3:
adjusted for age (continuous), sex, race, diabetes mellitus or hypertension, APOE, prevalent stroke, and incident stroke.
b One or more grades of change in imaging features vs none: Atherosclerosis Risk in Communities MRI study.
c p  0.05.
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macroscopic ischemic processes are not tightly
linked. Associations were generally positive, however,
and the number of incident strokes (n  28) may be
inadequate for reliable estimates of association. Lacu-
nar infarcts are not likely to be the proximal cause of
brain volume loss, but they might be associated with
more widespread cerebral microvascular disease,
which in turn is believed to be the core substrate of
brain dysfunction causing dementia.29-31
However, epidemiologic investigations,2,32 the-
oretical considerations,33 and neuropathologic
studies have raised the prospect that diabetes mel-
litus4,34 or hypertension3 might facilitate neurode-
generative mechanisms of the Alzheimer type.
Prior cross-sectional studies of vascular risk factors
and brain atrophy have generally shown associa-
tions with vascular risk factors.5,7,13,35-38 Our obser-
vations of the association of worsening SW and
prevalent diabetes suggests that some aspect of al-
tered glycemic control leads to synaptic loss, neu-
ronal death, and brain volume loss but does not
clarify the underlying mechanisms.
Carriers of the APOE 4 allele are at greater risk
for the appearance at a younger age of Alzheimer pa-
thology,39 but are not at greater risk for cerebrovascu-
lar disease. We were not able to demonstrate an
association in the cross-sectional analyses previously,5
nor currently in longitudinal analyses. Broken down
by race, an association between APOE 4 genotype
and VS was seen in white but not in black subjects.
APOE 4 genotype has a more attenuated relation-
ship to AD in black subjects,40 which perhaps ac-
counts for the lack of association in the group as a
whole.
Our observations imply that control of blood
sugar and blood pressure in midlife should reduce
the likelihood of ischemic and atrophic changes in
the brain in subsequent decades. Future clinical trials
in midlife aimed at these and other risk factors could
use imaging as a marker for relevant brain disease.
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Educate Your Patients with Diabetic Nerve Pain
Living with diabetes is a challenge for many patients—dealing with diabetic nerve pain on top of it
can make things daunting. Give them the answers they’re looking for with Diabetic Nerve Pain: A
Guide for Patients and Families, a free DVD and guidebook from the AAN Foundation. Help your
patients and their families understand how their pain could be related to their diabetes and about
approaches to pain relief. Direct them to view the free video at www.aan.com/patients. Copies also
are available by contacting memberservices@aan.com.
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